Weekly docetaxel in metastatic breast cancer patients: no superior benefits compared to three-weekly docetaxel.
Schröder CP, de Munck L, Westermann AM, Smit WM, Creemers GJ, de Graaf H, Stouthard JM, van Deijk G, Erjavec Z, van Bochove A, Vader W, Willemse PH.
Schröder CP, et al. Among authors: stouthard jm.
Eur J Cancer. 2011 Jun;47(9):1355-62. doi: 10.1016/j.ejca.2010.12.018. Epub 2011 Jan 19.
Eur J Cancer. 2011.
PMID: 21251813
Clinical Trial.